Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Correction to: A Multicentric Clinical Study to Evaluate Pharmacokinetics, Efficacy, and Safety of Immune Globulin Subcutaneous 20% Weekly/Biweekly Dosing in Treatment-Experienced Patients and Loading/Weekly Maintenance Dosing in Treatment-Naïve Patients with Primary Immunodeficiency.
Journal: Journal of clinical immunology
Published: February 02, 2026
Ex vivo bradykinin as a functional biomarker for angioedema with normal C1-inhibitor.
Journal: The journal of allergy and clinical immunology. Global
Published: January 22, 2026
A Multicentric Clinical Study to Evaluate Pharmacokinetics, Efficacy, and Safety of Immune Globulin Subcutaneous 20% Weekly/Biweekly Dosing in Treatment-Experienced Patients and Loading/Weekly Maintenance Dosing in Treatment-Naïve Patients with Primary Immunodeficiency.
Journal: Journal of clinical immunology
Published: January 08, 2025
Bradykinin measurement by liquid chromatography tandem mass spectrometry in subjects with hereditary angioedema enhanced by cold activation.
Journal: The journal of allergy and clinical immunology. Global
Published: January 03, 2025
Omalizumab response in patients with chronic idiopathic urticaria: Insights from the XTEND-CIU study.
Journal: Journal of the American Academy of Dermatology
Published: July 06, 2017
Showing 1-5 of 5
Last Updated: 09/26/2026